talquetamab
janssen
['multiple myeloma', 'lymphoma', 'monumental-1']
#ash22 day 1 highlights: significant results from monumental-1 trial, positive data for large b-cell lymphoma, infant hemophilia a and multiple myeloma 
A strategic healthcare consulting company founded upon the belief there is important work to be done at the intersection of data, health care, and technology.